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ABSTRACT
Adrenocortical carcinoma (ACC) is a rare aggressive malignancy. ACC with renal vein or inferior vena cava (IVC) thrombus is very 
rare. ACC with contralateral renal metastasis with renal vein thrombus has never been reported. Here we report first such case in the 
literature where a 40-year-old male presented with right flank pain and weight loss. Definitive preoperative diagnosis failed to be 
established. Intraoperatively, there was right adrenal mass with left renal vein thrombus invading its wall and extending upto IVC. 
Right adrenalectomy with left radical nephrectomy with thrombectomy was done. On cut specimen, there was a small mass lesion 
in the left kidney (upper pole). The diagnosis of ACC with left renal metastasis and renal vein tumor thrombus was confirmed by 
pathological and immune-histochemical examination. We faced various perioperative challenges in our case. Care must be taken 
in preoperative diagnostics, intraoperative planning, and postoperative management as ACC may present with contralateral renal 
metastasis and tumor thrombus.
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Adrenocortical carcinoma (ACC) is a rare aggressive malignancy.ACC with renal vein or inferior venacava (IVC) thrombus is very rare. In literature search upto 
2015, Ayati et al found only 44 cases of ACC with tumor thrombus 
extending to the IVC [1]. ACC with contralateral renal metastasis 
with renal vein thrombus has never been reported. Here we report 
first such case with peri-operative challenges.
CASE REPORT
A 40-year-old male presented with complaints of right flank 
pain with weight loss. The patient did not give any history 
of such in the past. On evaluation, the vitals were stable.The 
patient was found to be having large right adrenal mass with 
IVC (Level II) and left renal vein thrombus (Fig. 1a, 1b and 1c). 
The patient had multiple lung metastases also and the tumor 
was non-functional. Morning cortisol level was 12 micrograms 
per deciliter, morning plasma adrenocorticotropic hormone 
(ACTH) level was 15 picograms per milliliter and 24-hour 
urinary catecholamines and metanephrines were within normal 
limits.
Preoperatively, the patient had lower respiratory tract 
infection, so, he was started on antibiotics and patient was put 
onanticoagulant medication (low molecular weight heparin) 
in view of suspected bland left renal vein thrombus and to 
reduce thrombus propagation. He was planned for the right 
adrenalectomy with thrombectomy. Color Doppler was done in 
the morning of operation; it showed left renal vein thrombus just 
reaching into IVC. 
The patient was operated in a supine position with chevron 
incision. Kocherization was done and adrenal mass (15x14 cms) 
was dissected from the right kidney and IVC. Infrarenal IVC, 
right renal vessels, left renal artery and suprarenal IVC control 
was taken and clamped. IVC and left renal vein venotomy were 
done; there was thrombus in the left renal vein just extending 
upto IVC. Left renal vein thrombus was invading its wall and 
reaching into the renal sinus. Thrombectomy was not feasible 
Figure 1: 1a - CT scan coronal section showing Right adrenal mass 
(marked as star) with IVC and left renal vein thrombus (marked 
as arrow); 1b - CT scan axial section showing Right adrenal mass 
(marked as star) with IVC and left renal vein thrombus (marked as 
arrow)
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so, right adrenalectomy with left radical nephrectomy was done. 
On cut specimen, there was a mass lesion (2x2 centimeters) 
in the left kidney (Fig. 2a, 2b and 2c). On histopathological 
examination, the diagnosis of ACC with left renal metastasis and 
renal vein tumor thrombus was made and it was confirmed by 
immunohistochemical (IHC) examination using IHC markers 
Vimentin, Melan A and Ki67. (Fig. 3a, 3b, 3c and 3d).
Postoperatively, the patient was shifted in stable condition 
to an intensive care unit for monitoring. Approximately after 
6 hours, he developed persistent hypotension despite adequate 
resuscitation and inotropes. The endocrine opinion was sought 
and they advised serum cortisol levels and hydrocortisone 
infusion. Serum cortisol levels were low. The patient stabilized 
and hydrocortisone was tapered off gradually over 5 days. At 
one month follow-up, the patient is stable, wound is healthy 
and there is no adrenal insufficiency. The patient is planned for 
mitotane-based chemotherapy.
DISCUSSION
Most of ACC which are non-functional are difficult to diagnose 
[2]. Majority of patients present with tumor-related symptoms 
which can be secondary to local or systemic disease burden or 
hypersecretion of adrenal hormones,which is found in 50%-79% 
of adults and 90% of pediatric ACCs [3]. Hypercortisolism is the 
most common presentation of patients presenting with hormone 
excess (50%–80% of hormone-secreting ACCs) followed by 
adrenal androgens. Concurrent androgen and cortisol production 
is evident in roughly half of all ACC patients with hormone 
excess. Autonomous aldosterone secretion is rarely seen in ACC 
[4]. 
In metastatic ACC, multimodal therapy is often required. 
Debulking surgery should be considered in patients with the 
oligometastatic disease if > 80 % disease burden can be removed 
[5]. Althoughdebulking surgery may not improve survival, it 
may alleviate tumor-related side effects and enhance response 
to adjuvant therapies.In this patient, we considered debulking 
surgery as the patient had a resectable primary disease with IVC 
and opposite renal vein thrombus, which needed immediate 
surgical intervention. Adjuvant mitotane based chemotherapy 
was planned.
Recently, 304 patients were included in the First International 
Randomized trial in Locally Advanced and metastatic 
Adrenocortical Carcinoma treatment (FIRM-ACT) trial which 
compared the response of mitotane with etoposide-cisplatin-
doxorubicin (M-EDP)and mitotane-streptozotocin (M-Sz) as a 
first-line or second-line treatment.Overall survival was similar 
between the groups,but M-EDP was associated with better 
progression-free survival and objective response rate compared to 
M-Sz (5.0 vs. 2.1 months, 23.2 vs. 9.2%, respectively) [6]. Based 
on this trial, M-EDP can be considered the first line regimen for 
patients requiring systemic therapy.
Preoperatively, the patient was diagnosed to be having 
large right adrenal mass with IVC and left renal vein thrombus. 
But, during the operation he was found to be having left renal 
metastasis also. This could be explained as contrast-enhanced 
computed tomography scan of the abdomen was done one and 
a half months before surgery. During this period the renal mass 
might have increased in size. Many aggressive ACCs may grow 
quickly and involvement of adjacent structures may change, 
so, the imaging should be obtained as close as possible to 
the anticipated date of surgery [7]. In view of existing lower 
respiratory tract infection, we could not proceed for the surgery 
Figure 3: (3A) Hematoxylin-eosin stain showing adrenocortical 
carcinoma. (3B) H-E stain of renal mass. (3C)ACC metastasis 
with positive immunostaining pattern for Vimentin, (3D) ACC 
metastasis with positive immunostaining pattern for Melan A.
Figure 2: (2a) Specimen of right adrenal mass and left kidney with renal vein thrombus. (2b) Cut open specimen of left kidney showing upper polar 
mass (encircled). (2c) Diagrammatic representation (postoperative) of the right adrenal mass with IVC and left renal vein thrombus
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till it improved.So, meanwhile anticoagulants were started to 
reduce chances of thrombus propagation and further occlusion of 
left renal vein lumen. Anticoagulant therapy reduces thrombus 
propagation but does not produce clot lysis, thus risking 
post-thrombotic syndrome [8]. Level of tumor thrombus and 
vascularity of the left kidney was confirmed on Color Doppler 
before taking the patient to the operation room, as any change 
in renal vascularity or thrombus level would have changed 
the surgical planning.During operation, IVC and renal vessels 
control were taken to limit blood loss and to avoid migration 
of any tumor thrombus emboli. Venotomy and thrombectomy 
were not feasible as tumor thrombus was invading the vein 
wall. So, the decision of left radical nephrectomy was made. On 
cut specimen, there was a small mass at the upper pole of left 
kidney. Metastasis to left kidney with renal vein and IVC tumor 
thrombus can be explained by either of the two mechanisms. 
First, retrograde metastasis, the tumor might have spread to 
the left kidney via IVC and left renal vein tumor thrombus 
after the direct involvement of the IVC by ACC. Second, 
anterograde metastasis, direct hematogenous metastasis to the 
left kidney from ACC leading to the left renal vein and IVC 
thrombus. Implementing aggressive surgical therapy might be 
effective for the management of such cases [9], as the most 
important predictor of survival in patients with adrenal cancer 
is the adequacy of resection. In a case seriesof six patients by 
Figueroa et al, the patients of ACC with thrombus had 5-year 
survival rates ranging from 32% to 48% if it was completely 
resected, while the median survival was less than 1 year in 
patients undergoing incomplete excision [10].  
The left renal upper polar tumor was confirmed to be ACC 
metastasis on histopathological and immunohistochemical 
examination. Ascertaining the possibility of ACC metastasis to an 
organ is sometimes difficult. Especially it was imperative in our 
case to differentiate ACC metastasis from renal cell carcinoma. 
In such instances, a battery of immunostains which are 
expressed in most ACCs can provide evidence of adrenocortical 
differentiation [11], including Vimentin [12], MelanA (Mart1) 
[13] and Synaptophysin [14]. Approximately after six hours of the 
operation, our patient developed refractory hypotension. All the 
possible causes of postoperative hypotension were examined and 
ruled out. After endocrinology opinion injection hydrocortisone 
infusion was started in view of hypocortisolism. Ligation of 
the left adrenal vein during nephrectomy with contralateral 
adrenalectomy might have resulted in temporary post-operative 
hypotension due to hypocortisolism.
To the best of our knowledge, this is the first report of ACC 
with contralateral renal metastasis and tumor thrombus.
CONCLUSION
We faced various perioperative challenges. Care must be 
taken in preoperative diagnostics, intraoperative planning, and 
postoperative management as ACC with contralateral renal 
metastasis and tumor thrombus is possible. 
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